China’s new rules for investigator-initiated trials have sharply curtailed approvals since taking effect in May, according to investigators running ...
One combined protocol can de-risk FDA acceptance of foreign data, capture the U.S. safety and PK evidence regulators want, ...
FDA’s accelerated approval of GSK’s Jemperli gives some patients with locally advanced rectal cancer a treatment that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results